Introduction:
The generic drug market in France is a significant player in the pharmaceutical industry, with a growing demand for affordable alternatives to brand name medications. According to recent statistics, the generic drug market in France is valued at over €10 billion, accounting for approximately 40% of the total pharmaceutical market in the country. This trend is expected to continue as the cost-saving benefits of generic drugs become more widely recognized.
Top 10 Generic Drug Market Research & Intelligence Firms in France:
1. IMS Health France:
IMS Health France is a leading provider of market research and intelligence for the generic drug industry in France. With a market share of over 20%, IMS Health France offers valuable insights into market trends and competitive analysis.
2. Cegedim:
Cegedim is another key player in the generic drug market research sector in France. With a focus on data analytics and market intelligence, Cegedim provides comprehensive reports on market dynamics and growth opportunities.
3. Kantar Health France:
Kantar Health France is known for its in-depth market research and intelligence services for the generic drug industry. With a strong presence in France, Kantar Health offers valuable insights into market trends and competitor analysis.
4. Datamonitor Healthcare France:
Datamonitor Healthcare France is a trusted source of market research and intelligence for the generic drug industry in France. With a focus on data-driven insights, Datamonitor Healthcare provides valuable information on market dynamics and growth opportunities.
5. IQVIA France:
IQVIA France is a leading provider of market research and intelligence for the generic drug industry in France. With a focus on data analytics and market insights, IQVIA France offers comprehensive reports on market trends and competitive analysis.
6. GfK France:
GfK France is a key player in the generic drug market research sector in France. With a focus on consumer behavior and market trends, GfK France provides valuable insights into market dynamics and growth opportunities.
7. Decision Resources Group France:
Decision Resources Group France is a trusted source of market research and intelligence for the generic drug industry in France. With a focus on data-driven insights, Decision Resources Group France offers valuable information on market dynamics and growth opportunities.
8. GlobalData France:
GlobalData France is a leading provider of market research and intelligence for the generic drug industry in France. With a focus on data analytics and market insights, GlobalData France offers comprehensive reports on market trends and competitive analysis.
9. DRG France:
DRG France is a key player in the generic drug market research sector in France. With a focus on data-driven insights, DRG France provides valuable information on market dynamics and growth opportunities.
10. Fitch Solutions France:
Fitch Solutions France is a trusted source of market research and intelligence for the generic drug industry in France. With a focus on data analytics and market trends, Fitch Solutions France offers valuable insights into market dynamics and growth opportunities.
Insights:
The generic drug market in France is expected to continue its growth trajectory, driven by increasing demand for affordable medications and cost-saving benefits. According to forecasts, the generic drug market in France is projected to reach €15 billion by 2025, representing a significant opportunity for market research and intelligence firms in the country. As competition intensifies and regulatory changes impact the industry, staying ahead of market trends and understanding consumer behavior will be crucial for success in the generic drug market in France.
Related Analysis: View Previous Industry Report
